Sporicidin product clearances
This article was originally published in The Gray Sheet
Executive Summary
On Feb. 12, agency clears Sporicidin's three disinfectant products (a spray, a solution and towellettes) for marketing as "intermediate level" disinfectants, FDA says in a Feb. 12 "Talk Paper." The company's cold sterilizing solution and Sporicidin HD solution have not yet been cleared. "In order to get clearance, the firm must submit data showing that they are safe and effective," according to the agency. After participating in a government seizure of Sporicidin's products in December 1991, FDA reached a consent decree with the company in May 1992 ("The Gray Sheet" May 18, In Brief).
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.